Category: Cardiovascular Health Thursday, June 2, 2011 The Relevance of LDL Phenotype The LDL phenotype and size result has been removed from our most recent LPP™ report due to misinterpretation and lack of therapeutic guidance. LDL phenotype is an outdated designation to identify a large LDL type from a small LDL type. LDL phenotype was used in the past because accurate data on individual LDL subgroups was not available or inaccurate. Today the LPP™ test gives accurate information on large-buoyant and small-dense LDL subgroups and this is much more specific for treatment and ... Read More Posted by Elissa Rodriguez at Thursday, June 2, 2011 Cardiovascular Health Monday, May 16, 2011 SpectraCell Now Offers LPP™ Cardiovascular Testing in New York SpectraCell Laboratories has officially been granted a license to provide its Lipoprotein Particle Profile™ (LPP™) test, which assesses cardiovascular risk, to New York state physicians and patients. The recently patented LPP™ test has been commercially available to the other 49 states since 2006. SpectraCell began the process of acquiring a licensure in 2008 with an application submission the state of New York. The laboratory underwent an initial inspection by the New York State Department o... Read More Posted by Elissa Rodriguez at Monday, May 16, 2011 Cardiovascular Health Thursday, May 5, 2011 Why Do Omega-3 Fatty Acids Affect So Many Functions In Our Body? The answer is simple: cell membrane flexibility. Every cell has a cell membrane. When this cell membrane is rigid, it does not work well. When it is flexible, the chemicals that run our bodies - hormones, proteins, enzymes, vitamins, minerals, fats, etc - can move in and out of cells efficiently as needed, thus making the cells healthier, since the materials they need to function well are available. When the cells work well, the tissues that are made of cells work well... Read More Posted by Elissa Rodriguez at Thursday, May 5, 2011 Cardiovascular Health Thursday, January 27, 2011 SpectraCell Receives Patent on its LPP™ Cardiovascular Test Houston, TX- January 28, 2011. SpectraCell Laboratories has recently been awarded a patent on their Lipoprotein Particle Profile™ (LPP™) test which is used to measure cardiovascular risk. The LPP™ has been commercially available since 2006, and is a type of advanced cholesterol test that measures lipoprotein subgroups. The LPP™ gives more accurate estimation of cardiovascular risk compared to a routine cholesterol test. The patent was awarded for use of a “Method for Analyzing Blood for Lipop... Read More Posted by Elissa Rodriguez at Thursday, January 27, 2011 Cardiovascular Health
COVID-19 Testing Tests Our Science Providers Patients Draw Sites Contact Archives 2022 January 2021 December September June May April March February January 2020 November October September August July June May April March 2019 June May April March 2018 August July June May April March February 2017 December November September August July June May April March February January 2016 December November October September 2015 June March February January 2014 July May April March February January 2013 December November October September August July June May April March February January 2012 December November September August July June May April February January 2011 December November October August July June May April March February January 2010 December November October September July